DaVita Inc. (DVA)

82.17
NYSE
Prev Close 81.67
Day Low/High 81.21 / 82.78
52 Wk Low/High 53.51 / 92.16
Exchange NYSE
Shares Outstanding 122.00B
Market Cap 9.96B
P/E Ratio 13.28
Div & Yield N.A. (N.A)
Time to Shift Back to Earnings

Time to Shift Back to Earnings

The focus should now be on company news, not the Fed.

Davita downgraded at Raymond James

Portfolio Meets Test of Mr. Market

Portfolio Meets Test of Mr. Market

Gad Winning Value Portfolio is built to weather storms.

Earnings Roundup

Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...

DaVita HCP upgraded at Deutsche Bank

Winning Value Portfolio Update

Winning Value Portfolio Update

After the first three months of 2103, here's where it stands.

It's OK to Pay More for Quality

It's OK to Pay More for Quality

There's more to value investing than seeking a low price-to-earnings ratio.

Davita downgraded at Deutsche

Gad Winning Value Portfolio Update

Gad Winning Value Portfolio Update

So far so good in 2013, but two months is just two months.

Davita downgraded at Goldman

Davita rated new Overweight at JP Morgan

A Medical-Device Maker Attracts More Fund Buying

A Medical-Device Maker Attracts More Fund Buying

NxStage sees further purchases by Deerfield, and one of its biggest customers is a Buffett favorite.

Follow Buffett Into This Healthy Name

Follow Buffett Into This Healthy Name

We agree with his bullishness: DaVita Healthcare still has robust growth potential.

Davita numbers boosted at BofA/Merrill

A Crucial Peek Into Their Portfolios

A Crucial Peek Into Their Portfolios

When 13Fs roll in, I'll be keeping an eye on these particular stocks.

Berkshire Pays a Premium for DaVita

Berkshire Pays a Premium for DaVita

I would caution against mimicking the move and suggest waiting for a pullback.

The Week Ahead: Investors Eye Fed Meeting, More Earnings

The Week Ahead: Investors Eye Fed Meeting, More Earnings

Contributor Ken Shreve takes a look at upcoming economic data plus some key earnings reports for the week of July 30.

Hard to Argue With This Kind of Action

Hard to Argue With This Kind of Action

These healthcare stocks may not be in 'hot' sectors, but they are outpacing the market nonetheless.

Two Important Questions

Two Important Questions

Why has the market plummeted? And what is the market's outlook?

It Is Not the Eve of Destruction

The month of May has been a painful reminder of how humbling the investment business can be. The Eastern world it is explodin', Violence flarin', bullets loadin', You're old enough to kill but not for votin', You don't believe in war, what's that gu...

Davita downgraded at Baird

How Nike, Apple Win With 'Repeatability'

How Nike, Apple Win With 'Repeatability'

Chris Zook, author of Repeatability, explains how Nike and Apple have grown successfully.

3 Stocks Ready to Slice Through Resistance

3 Stocks Ready to Slice Through Resistance

Well-established resistance could soon fall for MMM, DVA and CPL.

It's Smart to Copy Great Investors

Instead of looking at thousands of stocks, look to see what the smart money is doing first.

Analyst Actions -- 9/30/2011

Here are today's top research calls.